A positive inotropic effect of ATP in the human cardiac atrium

American Journal of Physiology - Heart and Circulatory Physiology - Tập 294 Số 4 - Trang H1716-H1723 - 2008
Ulrich Gergs1, Peter Boknı́k, Wilhelm Schmitz, Andreas Simm, RE Silber, Joachim Neumann
1Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Magdeburger Str. 4, D-06112 Halle, Germany.

Tóm tắt

We studied contractile effects in isolated electrically driven (1 Hz) atrial preparations from patients undergoing cardiac bypass surgery. ATP concentration dependently (10, 30, and 100 μM) and rapidly decreased force of contraction (negative inotropic effect, NIE) and thereafter more slowly increased force of contraction. The maximum positive inotropic effect (PIE) at 100 μM ATP amounted to 152% of the predrug value ( n = 9) and was stable and could be washed out fast and completely. The PIE did not affect time parameters of contraction (time to peak tension and time of relaxation). Moreover, a similar NIE and PIE were noted with adenosine 5′- O-(2-thiotriphosphate) (100 μM). In contrast 2-methyl-thio-ATP did not exert a NIE but only a PIE. In a second set of experiments, preparations were first incubated for 30 min with purinoreceptor antagonists and, in their continuous presence, 100 μM ATP was applied. However, the PIE and NIE of ATP could neither be blocked with suramin (100 and 500 μM), pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (50 μM), nor reactive blue 2 (30, 100, and 500 μM), which are known blockers for subtypes of P2 receptors, or 1,3-dipropyl-cyclopentvl-xanthine (1 and 10 μM), a subtype (A1 adenosine) P1 receptor blocker. Likewise, the inhibitor of phospholipase C (PLC) activity (U-73122) and the inhibitor of adenylate cyclase activity (SQ-022563) (10 μM each) failed to affect the NIE and the PIE of ATP. We tentatively suggest that the PIE of ATP might be mediated via P2X4-like receptors. In summary, we describe a novel biphasic effect of ATP on force contraction in the isolated human atrium. It is conceivable that ATP plays a physiological role in the human heart, for instance, after cardiac injury to sustain contractility.

Từ khóa


Tài liệu tham khảo

10.1124/pr.58.3.3

10.1073/pnas.90.1.312

10.1016/j.yjmcc.2005.09.002

Behnke N, Müller W, Neumann J, Schmitz W, Scholz H, Stein B. Differential antagonism by 1,3-dipropylxanthine-8-cyclopentylxanthine and 9-chloro-2(2-furanyl)-5,6-dihydro-1,2,4-triazolo (1,5-c)quinazolin-5-imine of the effects of adenosine derivatives in the presence of isoprenaline on contractile response and cAMP content in cardiomyocytes. Evidence for the coexistence of A1- and A2-adenosine receptors on cardiomyocytes. J Pharmacol Exp Ther 254: 1017–1023, 1990.

Berne RM. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204: 317–322, 1963.

10.1016/0014-5793(95)01203-Q

10.1074/jbc.M000894200

10.1007/BF00500095

10.1161/01.RES.65.5.1201

10.1161/01.RES.68.3.797

10.1016/0167-4889(85)90082-5

10.1038/sj.bjp.0705459

10.1111/j.1476-5381.1970.tb10646.x

Burnstock g. Purinergic nerves. Pharmacol Rev 24: 509–581, 1972.

10.1111/j.1476-5381.1981.tb08741.x

10.1523/JNEUROSCI.16-08-02495.1996

10.1073/pnas.95.26.15735

Day HJ, Holmsen H. Concepts of the blood platelet release reaction. Ser Haematol 4: 3–27, 1971.

10.1113/jphysiol.1929.sp002608

10.1113/jphysiol.2004.069245

10.1113/jphysiol.1978.sp012231

10.1074/jbc.274.2.755

10.1074/jbc.M600442200

Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev 46: 143–156, 1994.

10.1007/BF00170884

Gergs U, Boknik P, Schmitz W, Simm A, Silber RE, Illes P, Neumann J. ATP modified contraction in the human heart (Abstract). Naunyn-Schmiedeberg's Arch Pharmacol 375, Suppl 1: 63, 2007.

10.1161/01.RES.72.1.65

Gupta RC, Neumann J, Watanabe AM. Comparison of adenosine and muscarinic receptor mediated effects on phosphatase inhibitor-1 activity in the heart. J Pharmacol Exp Ther 266: 16–22, 1993.

10.2170/jjphysiol.41.327

10.1085/jgp.20028540

10.1096/fj.01-0445fje

10.1038/sj.bjp.0703059

Jorgensen S. Breakdown of adenine and hypoxanthine nucleotides and nucleosides in human plasma. Acta Pharmacol Toxicol (Copenh) 12: 294–302, 1956.

Kennedy C, Qi AD, Herold CL, Harden TK, Nicholas RA. ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor. Mol Pharmacol 57: 926–931, 2000.

10.1177/1073858404274063

Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Séguéla P, Voigt M, Humphrey PP. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53: 107–118, 2001.

10.1152/jappl.2000.88.6.1962

10.1152/ajpheart.00937.2001

10.1152/ajpcell.1998.275.3.C766

10.1007/s002100000312

10.1113/jphysiol.1988.sp017157

10.1007/BF00165807

10.1111/j.1476-5381.1993.tb13759.x

10.1152/ajpheart.2001.281.1.H334

10.1152/ajpheart.2000.279.4.H1472

10.1016/j.bcp.2007.07.033

10.1161/01.RES.34.4.455

10.1007/BF00717746

10.1152/ajpheart.2000.279.2.H630

10.1152/ajpheart.1997.273.5.H2380

10.1152/ajpheart.1993.264.2.H310

Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50: 413–492, 1998.

10.1136/hrt.55.3.291

10.1161/01.RES.67.4.1007

10.1096/fj.05-4749com

10.1093/emboj/17.4.898

10.1113/jphysiol.2007.133314

10.1007/BF00928361

Uozumi H, Kudoh S, Zou Y, Harada K, Yamazaki T, Komuro I. Autocrine release of ATP mediates mechanical stress-induced cardiomyocytes hypertrophy (Abstract). Circulation 98: I624, 1998.

10.1111/j.1476-5381.1996.tb15748.x

Vahlensieck U, Boknik P, Gombosova I, Huke S, Knapp J, Linck B, Lüss H, Müller FU, Neumann J, Deng MC, Scheld HH, Jankowski H, Schlüter H, Zidek W, Zimmermann N, Schmitz W. Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations. J Pharmacol Exp Ther 288: 805–813, 1999.

10.1152/physrev.2001.81.2.767

10.1016/j.pharmthera.2005.08.014

10.1124/jpet.107.125815

10.1016/0014-2999(87)90418-3

10.1161/01.RES.0000217402.73402.cd

10.1152/ajpheart.00079.2004

10.1161/01.RES.78.4.525

10.1097/00005344-200006000-00008

Thông tin
Thông tin xuất bản

American Journal of Physiology - Heart and Circulatory Physiology

Tập 294 Số 4

H1716-H1723

Thông tin tác giả